Arrowstreet Capital, Limited Partnership Astrazeneca PLC Transaction History
Arrowstreet Capital, Limited Partnership
- $136 Billion
- Q2 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,155,576 shares of AZN stock, worth $89.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,155,576
Previous 3,591,620
67.83%
Holding current value
$89.8 Million
Previous $264 Million
69.41%
% of portfolio
0.06%
Previous 0.22%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.04 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.2 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.67 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.44 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.42 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...